Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.99
-0.06 (-0.60%)
Jun 26, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 503.77 million as of June 26, 2026. Its market cap has increased by 2.98% in one year.
Market Cap
503.77M
Enterprise Value
271.10M
Revenue
96.30M
Ranking
n/a
PE Ratio
15.52
Stock Price
9.99
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 503.77M, an increase of 9,540.39%. That is a compound annual growth rate of 19.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 503.77M | -19.46% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.54B |
| PYC Therapeutics | 1.51B |
| Clarity Pharmaceuticals | 675.65M |
| Racura Oncology | 432.19M |
| Tetratherix | 324.70M |
| Starpharma Holdings | 292.70M |
| Orthocell | 206.91M |
| Alterity Therapeutics | 121.80M |